PWR
63
3
CRM
65
6
OMC
37
2
MTCH
62
22
OI
23
3
INTU
54
2
STZ
42
2
IP
53
3
HOG
29
4
PX
56
3
CNP
59
17
NEE
39
9
SYF
78
7
ALL
37
3
CMA
42
3
BF.B
35
2
NOV
45
2
JCI
44
7
AMP
43
2
TXT
46
4
PWR
63
3
CRM
65
6
OMC
37
2
MTCH
62
22
OI
23
3
INTU
54
2
STZ
42
2
IP
53
3
HOG
29
4
PX
56
3
CNP
59
17
NEE
39
9
SYF
78
7
ALL
37
3
CMA
42
3
BF.B
35
2
NOV
45
2
JCI
44
7
AMP
43
2
TXT
46
4
Financhill
Back

Keros Therapeutics Vs. Regeneron Pharmaceuticals Industry Stock Comparison

Sell
4

KROS
Keros Therapeutics

Last Price:
$17.04
Seasonality Move:
16.43%
Sell
42

REGN
Regeneron Pharmaceuticals

Last Price:
$701.91
Seasonality Move:
10.8%
Sell
4
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $17.03. The Score for KROS is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
42
Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals [REGN] share price is $701.85. The Score for REGN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • REGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $17.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals's stock price today?

  • The Regeneron Pharmaceuticals share price today is $701.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -11.49 Sell
Relative Strength Index (14 RSI): 22.6 Sell
Chaikin Money Flow: -285503 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.79 - 67.83) Sell
Bollinger Bands (100): (41.67 - 65.17) Sell

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -29.66 Sell
Relative Strength Index (14 RSI): 27.8 Sell
Chaikin Money Flow: -1643849 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (727.49 - 769.33) Sell
Bollinger Bands (100): (805.13 - 1140.25) Sell

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.3 Sell
20-day SMA: 46.77 Sell
50-day SMA: 55 Sell
200-day SMA: 53.85 Sell
8-day EMA: 25.85 Sell
20-day EMA: 40.07 Sell
50-day EMA: 49.85 Sell
200-day EMA: 51.91 Sell

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 729.36 Sell
20-day SMA: 747.95 Sell
50-day SMA: 826.21 Sell
200-day SMA: 980.92 Sell
8-day EMA: 726.23 Sell
20-day EMA: 750.86 Sell
50-day EMA: 823.81 Sell
200-day EMA: 934.41 Sell

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $0.20 per share.

Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.58 per share, and a decrease next year of $0.01 per share.

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regeneron Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):